Prenatal screening and diagnosis

Guidelines, reviews, epidemiology

Amniocentesis, chorionic villus sampling

• Europe
  • Ultrasound in Obstetrics & Gynecology
    • New approach for estimating risk of miscarriage after chorionic villus sampling [2020]
• Germany
  • Ultraschall in der Medizin
    • DEGUM Recommendations on Diagnostic Puncture in Prenatal Medicine [2023]
• International
  • BMC Pregnancy and Childbirth
    • Network meta-analysis of randomized controlled trials comparing the effectiveness of different treatments in reducing amniocentesis-associated pain and anxiety [2023]
  • International Society of Ultrasound in Obstetrics and Gynecology
    • ISUOG Practice Guidelines: invasive procedures for prenatal diagnosis [2016]
  • Medicina
    • Invasive Prenatal Diagnostic Testing for Aneuploidies in Singleton Pregnancies: A Comparative Review of Major Guidelines [2022]
  • Ultrasound in Obstetrics & Gynecology
    • Trials and tribulations of meta-analyzing procedure-related risks of amniocentesis and chorionic villus sampling [2019]
    • Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis [2019]
• Republic of Korea
  • Journal of Korean Medical Science
    • Clinical Practice Guidelines for Prenatal Aneuploidy Screening and Diagnostic Testing from Korean Society of Maternal-Fetal Medicine: (2) Invasive Diagnostic Testing for Fetal Chromosomal Abnormalities [2021]
• Spain
  • Journal of Medical Genetics
    • Guidelines for NGS procedures applied to prenatal diagnosis by the Spanish Society of Gynecology and Obstetrics and the Spanish Association of Prenatal Diagnosis [2024]
• Taiwan
  • Journal of the Formosan Medical Association
    • Complication rates after chorionic villus sampling and midtrimester amniocentesis: A 7-year national registry study [2019]
• United Kingdom
  • Journal of Clinical Medicine
    • Pregnancy Loss Following Amniocentesis or CVS Sampling—Time for a Reassessment of Risk [2014]
  • Royal College of Obstetricians and Gynaecologists
    • Amniocentesis and Chorionic Villus Sampling [2021]
• United States
  • Association for Molecular Pathology
    • Laboratory Guidelines for Detection, Interpretation, and Reporting of Maternal Cell Contamination in Prenatal Analyses [2011]
• {Related topics}
  • Topic
    • Prenatal screening and diagnosis

Cystic fibrosis: prenatal screening and diagnosis

• Europe
  • European Journal of Human Genetics
    • The improvement of the best practice guidelines for preimplantation genetic diagnosis of cystic fibrosis: toward an international consensus [2016]
  • Journal of Cystic Fibrosis
    • Benchmarks for Cystic Fibrosis carrier screening: A European consensus document [2010]
• France
  • Genes
    • Prenatal Ultrasound Suspicion of Cystic Fibrosis in a Multiethnic Population: Is Extensive CFTR Genotyping Needed? [2021]
• United Kingdom
  • Prenatal Diagnosis
    • Non-invasive prenatal diagnosis for cystic fibrosis: detection of paternal mutations, exploration of patient preferences and cost analysis [2015]
  • UK National Screening Committee
    • Cystic fibrosis (pregnancy)
• {Related topics}
  • Topic
    • Prenatal screening and diagnosis
    • Cystic fibrosis

Down syndrome: prenatal screening and diagnosis

• Australia
  • Australian Prescriber
    • Non-invasive prenatal testing for Down syndrome [2014]
• Canada
  • BMC Pregnancy and Childbirth
    • Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategies [2020]
  • Implementation Science
    • Theory-based approach to developing an implementation plan to support the adoption of a patient decision aid for Down syndrome prenatal screening [2021]
  • PLoS ONE
    • Cost-effectiveness of prenatal screening and diagnostic strategies for Down syndrome: A microsimulation modeling analysis [2019]
• China
  • BMJ Open
    • Introducing the non-invasive prenatal testing for detection of Down syndrome in China: a cost-effectiveness analysis [2021]
  • Frontiers in Public Health
    • A Cost-Effectiveness Analysis of Screening Strategies Involving Non-Invasive Prenatal Testing for Trisomy 21 [2022]
• Denmark
  • Acta Obstetricia et Gynecologica Scandinavica
    • Impact of a prenatal screening program on the Down syndrome phenotype: An interrupted time series analysis [2023]
    • National screening guidelines and developments in prenatal diagnoses and live births of Down syndrome in 1973–2016 in Denmark [2018]
  • BMJ
    • Impact of a new national screening policy for Down's syndrome in Denmark: population based cohort study [2009]
  • JMIR Research Protocols
    • Informed Choice for Participation in Down Syndrome Screening: Development and Content of a Web-Based Decision Aid [2015]
  • Prenatal Diagnosis
    • Is the first-trimester combined screening result associated with the phenotype of Down syndrome? A population-based cohort study [2023]
• Europe, Oceania, United States
  • European Journal of Human Genetics
    • Down syndrome screening and diagnosis practices in Europe, United States, Australia, and New Zealand from 1990-2021 [2023]
• Finland
  • Journal of Perinatal Medicine
    • Cost of providing cell-free DNA screening for Down syndrome in Finland using different strategies [2021]
• France
  • BMC Pregnancy and Childbirth
    • Does women’s place of birth affect their opportunity for an informed choice about Down syndrome screening? A population-based study in France [2021]
  • Midwifery
    • Why do French women refuse to have Down's syndrome screening by maternal serum testing? A mixed methods study [2022]
• Germany
  • Fetal Diagnosis and Therapy
    • Universal Cell Free DNA or Contingent Screening for Trisomy 21: Does It Make a Difference? A Comparative Study with Real Data [2022]
• International
  • International Journal of Environmental Research and Public Health
    • Demographic Assessment of Down Syndrome: A Systematic Review [2021]
  • PLoS ONE
    • The implementation and impact of non-invasive prenatal testing (NIPT) for Down's syndrome into antenatal screening programmes: A systematic review and meta-analysis [2024]
  • Prenatal Diagnosis
    • Has noninvasive prenatal testing impacted termination of pregnancy and live birth rates of infants with Down syndrome? [2017]
• Netherlands
  • BMC Pregnancy and Childbirth
    • Reasons for accepting or declining Down syndrome screening in Dutch prospective mothers within the context of national policy and healthcare system characteristics: a qualitative study [2016]
  • European Journal of Pediatrics
    • Neonatal mortality and morbidity in Down syndrome in the time of prenatal aneuploidy testing: a retrospective cohort study [2023]
  • Prenatal Diagnosis
    • Does non-invasive prenatal testing affect the livebirth prevalence of Down syndrome in the Netherlands? A population-based register study [2021]
• New Zealand
  • Health New Zealand
    • Antenatal Screening for Down Syndrome and Other Conditions: Guidelines for Health Practitioners [2024]
    • Antenatal screening for Down syndrome and other conditions: Guidelines for nuchal translucency (NT) and crown rump length (CRL) measurement [2015]
    • Antenatal Screening for Down Syndrome and Other Conditions
  • Starship
    • Down Syndrome - management of the neonate
• Norway
  • Tidsskrift for Den norske legeforening
    • Trisomy 21 – incidence, diagnostics and pregnancy terminations 1999–2018 [2021]
• Republic of Korea
  • Journal of Korean Medical Science
    • Estimating Nationwide Prevalence of Live Births with Down Syndrome and Their Medical Expenditures in Korea [2019]
• Slovenia
  • PLoS ONE
    • Impact of prenatal screening on the prevalence of Down syndrome in Slovenia [2017]
• South Africa
  • South African Medical Journal
    • Trisomy 21 screening with alpha software and the Fetal Medicine Foundation algorithm [2023]
• Spain
  • Cost Effectiveness and Resource Allocation
    • The consequences of implementing non-invasive prenatal testing with cell-free foetal DNA for the detection of Down syndrome in the Spanish National Health Service: a cost-effectiveness analysis [2019]
• Taiwan
  • BMC Pregnancy and Childbirth
    • The impact of prenatal screening tests on prenatal diagnosis in Taiwan from 2006 to 2019: a regional cohort study [2022]
• Thailand
  • BMC Health Services Research
    • Fetal Down syndrome screening models for developing countries; Part II: Cost-benefit analysis [2019]
    • Fetal Down syndrome screening models for developing countries; Part I: Performance of Maternal Serum Screening [2019]
  • International Journal of Public Health
    • Performance of Serum Quad Test in Screening for Fetal Down Syndrome in a Large-Scale Unselected Population in a Developing Country [2023]
  • PLoS ONE
    • Ethnic-specific reference range affects the efficacy of quadruple test as a universal screening for Down syndrome in a developing country [2021]
• United Kingdom
  • Journal of Medical Screening
    • Antenatal screening for Down’s syndrome: Revised nuchal translucency upper truncation limit due to improved precision of measurement [2021]
  • NHS England
    • Down’s syndrome screening quality assurance support service: report types
    • Down’s syndrome screening quality assurance support service
  • NHSGGC
    • Trisomy 21 - Care Pathway
  • Public Health England
    • Down’s syndrome screening: chance calculation software requirements
  • UK National Screening Committee
    • Down's syndrome
• United States
  • American College of Medical Genetics and Genomics
    • Technical standards and guidelines: prenatal screening for Down syndrome that includes first-trimester biochemistry and/or ultrasound measurements [2009]
  • International Journal of Women's Health
    • Noninvasive screening tools for Down syndrome: a review [2013]
  • JAMA Network Open
    • Association Between Rates of Down Syndrome Diagnosis in States With vs Without 20-Week Abortion Bans From 2011 to 2018 [2023]
  • Journal of Medical Screening
    • Prenatal serum screening for Down syndrome and neural tube defects in the United States: Changes in utilization patterns from 2012 to 2020 [2021]
  • PLOS Biology
    • Chloe’s Law: A Powerful Legislative Movement Challenging a Core Ethical Norm of Genetic Testing [2015]
  • Prenatal Diagnosis
    • Prenatal diagnosis of Down syndrome: a systematic review of termination rates (1995–2011) [2012]

Fragile X syndrome: prenatal screening and diagnosis

• China
  • Molecular Genetics & Genomic Medicine
    • Development of Chinese genetic reference panel for Fragile X Syndrome and its application to the screen of 10,000 Chinese pregnant women and women planning pregnancy [2020]
• Europe
  • European Molecular Genetics Quality Network
    • EMQN best practice guidelines for the molecular genetic testing and reporting of fragile X syndrome and other fragile X-associated disorders [2015]
• India
  • Indian Academy of Pediatrics
    • Consensus Statement of the Indian Academy of Pediatrics on Diagnosis and Management of Fragile X Syndrome in India [2019]
• Taiwan
  • Scientific Reports
    • Fragile X syndrome carrier screening in pregnant women in Chinese Han population [2019]
• United Kingdom
  • Genes
    • Development of Genetic Testing for Fragile X Syndrome and Associated Disorders, and Estimates of the Prevalence of FMR1 Expansion Mutations [2016]
  • UK National Screening Committee
    • Fragile X
• United States
  • American College of Medical Genetics and Genomics
    • Laboratory testing for fragile X, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG) [2021]
• {Related topics}
  • Topic
    • Prenatal screening and diagnosis

Maternal blood screening, non-invasive prenatal testing

• Australia
  • Australian Family Physician
    • Non-invasive prenatal testing [2017]
• Australia, Europe, United States
  • Acta Obstetricia et Gynecologica Scandinavica
    • Current use of noninvasive prenatal testing in Europe, Australia and the USA: A graphical presentation [2020]
• Austria, Germany, Switzerland
  • Ultraschall in der Medizin
    • Cell-Free DNA Testing for Fetal Chromosomal Anomalies in clinical practice: Austrian-German-Swiss Recommendations for non-invasive prenatal tests (NIPT) [2015]
• Brazil
  • Revista da Associação Médica Brasileira
    • Use of cell-free fetal nucleic acids in maternal blood for prenatal diagnosis: the reality of this scenario in Brazil [2012]
• Canada
  • BMJ Open
    • Expansion of non-invasive prenatal screening to the screening of 10 types of chromosomal anomalies: a cost-effectiveness analysis [2023]
  • Canadian Agency for Drugs and Technologies in Health
    • Non-invasive Prenatal Testing: A Review of the Cost Effectiveness and Guidelines [2014]
  • Ontario Health
    • Perspectives of Pregnant People and Clinicians on Noninvasive Prenatal Testing: A Systematic Review and Qualitative Meta-synthesis [2019]
    • Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment [2019]
• Denmark
  • Ultrasound in Obstetrics & Gynecology
    • Potential diagnostic consequences of applying non-invasive prenatal testing: population-based study from a country with existing first-trimester screening [2014]
• Europe
  • European Journal of Human Genetics
    • The ethical landscape(s) of non-invasive prenatal testing in England, France and Germany: findings from a comparative literature review [2022]
  • Prenatal Diagnosis
    • Recommended practice for laboratory reporting of non-invasive prenatal testing of trisomies 13, 18 and 21: a consensus opinion [2017]
• Europe, United States
  • European Society of Human Genetics
    • Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening [2015]
• Germany
  • Development & Reproduction
    • A Normative Review on Non-Invasive Prenatal Diagnosis (NIPD): Focusing on the German Discussion on PrenaTest [2021]
  • European Journal of Human Genetics
    • Non-invasive prenatal testing in Germany: a unique ethical and policy landscape [2023]
• International
  • Acta Obstetricia et Gynecologica Scandinavica
    • Noninvasive prenatal testing and maternal obesity: A review [2020]
  • American Journal of Bioethics
    • Non-Invasive Prenatal Testing for "Non-Medical" Traits: Ensuring Consistency in Ethical Decision-Making [2023]
  • International Journal of Women's Health
    • Non-invasive prenatal testing: a review of international implementation and challenges [2015]
  • International Society of Ultrasound in Obstetrics and Gynecology
    • ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practice [2017]
    • ISUOG consensus statement on the impact of non-invasive prenatal testing (NIPT) on prenatal ultrasound practice [2014]
  • Medical Decision Making
    • Impact of Structural Differences on the Modeled Cost-Effectiveness of Noninvasive Prenatal Testing [2024]
  • Medicine, Health Care and Philosophy
    • "Overestimated technology - underestimated consequences" - reflections on risks, ethical conflicts, and social disparities in the handling of non-invasive prenatal tests (NIPTs) [2023]
  • PLoS ONE
    • Genome-Wide, Non-Invasive Prenatal Testing for rare chromosomal abnormalities: A systematic review and meta-analysis of diagnostic test accuracy [2024]
  • Prenatal Diagnosis
    • Inclusion of sex chromosomes in noninvasive prenatal testing in Asia, Australia, Europe and the USA: A survey study [2023]
    • Global perspectives on clinical adoption of NIPT [2015]
• Italy
  • Ministero della Salute
    • Guidelines DNA-based Non-Invasive Prenatal Testing - NIPT [2015]
• Japan
  • International Journal of Environmental Research and Public Health
    • Non-Invasive Prenatal Testing (NIPT) Implementation in Japan: A Comparison with the United Kingdom, Germany, Italy, Sweden, and Taiwan [2022]
• Netherlands
  • Acta Obstetricia et Gynecologica Scandinavica
    • Uptake of fetal aneuploidy screening after the introduction of the non-invasive prenatal test: A national population-based register study [2021]
  • American Journal of Human Genetics
    • TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands [2019]
  • Bioethics
    • Rethinking counselling in prenatal screening: An ethical analysis of informed consent in the context of non-invasive prenatal testing (NIPT) [2020]
  • European Journal of Human Genetics
    • Experiences of pregnant women with genome-wide non-invasive prenatal testing in a national screening program [2023]
• Norway
  • Acta Obstetricia et Gynecologica Scandinavica
    • Controversies in implementing non-invasive prenatal testing in a public antenatal care program [2022]
• United Kingdom
  • Genetics Research
    • Cytogenomic results following high-chance non-invasive prenatal testing: a UK national audit [2020]
  • NHS England
    • Screening for Down’s syndrome, Edwards’ syndrome and Patau’s syndrome: non-invasive prenatal testing (NIPT)
  • Prenatal Diagnosis
    • Delivering an accredited non-invasive prenatal diagnosis service for monogenic disorders and recommendations for best practice [2018]
  • Royal College of Obstetricians and Gynaecologists
    • Non-invasive Prenatal Testing for Chromosomal Abnormality using Maternal Plasma DNA [2014]
• United States
  • AJP Reports
    • Obstetrician and Gynecologist Utilization of the Noninvasive Prenatal Testing Expanded Option [2015]
  • American College of Medical Genetics and Genomics
    • Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG) [2023]
    • Systematic evidence-based review: The application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies [2022]
    • Diagnostic cytogenetic testing following positive noninvasive prenatal screening results: a clinical laboratory practice resource of the American College of Medical Genetics and Genomics (ACMG) [2017]
    • Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics [2016]
  • Annual Review of Biomedical Data Science
    • Noninvasive Prenatal Testing Using Circulating DNA and RNA: Advances, Challenges, and Possibilities [2023]
  • BMC Pregnancy and Childbirth
    • Patient perspectives on noninvasive prenatal testing among black women in the United States: a scoping review [2023]
  • National Society of Genetic Counselors
    • Noninvasive Prenatal Testing/Noninvasive Prenatal Diagnosis: the Position of the National Society of Genetic Counselors [2013]
  • PLoS ONE
    • An Economic Analysis of Cell-Free DNA Non-Invasive Prenatal Testing in the US General Pregnancy Population [2015]
    • A Cost-Effectiveness Analysis of First Trimester Non-Invasive Prenatal Screening for Fetal Trisomies in the United States [2015]
  • Prenatal Diagnosis
    • Noninvasive prenatal screening for patients with high body mass index: Evaluating the impact of a customized whole genome sequencing workflow on sensitivity and residual risk [2020]
    • Commercial Landscape of noninvasive prenatal testing in the United States [2013]
    • Best Ethical Practices for Clinicians and Laboratories in the Provision of Non-Invasive Prenatal Testing [2013]
  • Society for Maternal-Fetal Medicine
    • SMFM Statement: clarification of recommendations regarding cell-free DNA aneuploidy screening [2015]
    • #36: Prenatal aneuploidy screening using cell-free DNA [2015]
• Vietnam
  • Journal of Maternal-Fetal & Neonatal Medicine
    • High prevalence of maternal mosaic monosomy X in pregnant women in Vietnam [2023]
• {Related topics}
  • Topic
    • Prenatal screening and diagnosis

Preimplantation diagnosis

• Brazil
  • Brazilian Journal of Medical and Biological Research
    • Practices and ethical concerns regarding preimplantation diagnosis. Who regulates preimplantation genetic diagnosis in Brazil? [2014]
• Canada
  • Canadian Fertility & Andrology Society
    • Preimplantation genetic testing for aneuploidy: A Canadian Fertility and Andrology Society Guideline [2021]
  • Society of Obstetricians and Gynaecologists of Canada
    • Prenatal Testing After IVF With Preimplantation Genetic Testing for Aneuploidy [2020]
• China
  • BMC Pregnancy and Childbirth
    • Cost-effectiveness of preimplantation genetic testing for aneuploidy for women with subfertility in China: an economic evaluation using evidence from the CESE-PGS trial [2023]
  • Human Reproduction
    • Chinese experts' consensus guideline on preimplantation genetic testing of monogenic disorders [2023]
• Europe
  • European Society of Human Genetics
    • The use of polygenic risk scores in pre-implantation genetic testing: an unproven, unethical practice [2022]
  • European Society of Human Reproduction and Embryology
    • ESHRE PGT Consortium data collection XXI: PGT analyses in 2018 [2023]
    • ESHRE survey results and good practice recommendations on managing chromosomal mosaicism [2022]
    • The ethics of preconception expanded carrier screening in patients seeking assisted reproduction [2021]
    • ESHRE PGT Consortium good practice recommendations for the organisation of PGT [2020]
    • ESHRE PGT Consortium good practice recommendations for the detection of structural and numerical chromosomal aberrations [2020]
    • ESHRE PGT Consortium good practice recommendations for the detection of monogenic disorders [2020]
    • ESHRE PGT Consortium and SIG Embryology good practice recommendations for polar body and embryo biopsy for PGT [2020]
• International
  • Acta Obstetricia et Gynecologica Scandinavica
    • A systematic review on concurrent aneuploidy screening and preimplantation genetic testing for hereditary disorders: What is the prevalence of aneuploidy and is there a clinical effect from aneuploidy screening? [2020]
  • Genetics in Medicine
    • A review of normative documents on preimplantation genetic testing: Recommendations for PGT-P [2022]
  • Human Reproduction Update
    • Screening embryos for polygenic disease risk: a review of epidemiological, clinical, and ethical considerations [2024]
  • Reproductive Biology and Endocrinology
    • Commentary on two recently published formal guidelines on management of “mosaic” embryos after preimplantation genetic testing for aneuploidy (PGT-A) [2021]
    • The 2019 PGDIS position statement on transfer of mosaic embryos within a context of new information on PGT-A [2020]
• Nordic countries
  • Acta Obstetricia et Gynecologica Scandinavica
    • Preimplantation genetic testing practices in the Nordic countries [2020]
    • Preimplantation genetic testing legislation and accessibility in the Nordic countries [2020]
• Sweden
  • Human Reproduction
    • Preimplantation genetic testing and child health: a national register-based study [2023]
• Turkey
  • Reproductive BioMedicine Online
    • Good laboratory practice for PGT-M: Turkish Society of Reproductive Medicine guidelines [2024]
• United Kingdom
  • Human Fertilisation and Embryology Authority
    • PGT-M conditions
  • Journal of Assisted Reproduction and Genetics
    • Does PGT-A improve assisted reproduction treatment success rates: what can the UK Register data tell us? [2022]
  • NHS England
    • Clinical commissioning policy: pre-implantation genetic testing of embryos at significant risk of serious genetic conditions [2023]
    • Pre-implantation Genetic Diagnosis (PGD) [2014]
• United Kingdom, United States
  • Human Reproduction
    • The status of preimplantation genetic testing in the UK and USA [2020]
• United States
  • AMA Journal of Ethics
    • Who Should Regulate Preimplantation Genetic Diagnosis in the United States? [2018]
  • American College of Medical Genetics and Genomics
    • Clinical utility of polygenic risk scores for embryo selection: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG) [2024]
  • American College of Obstetricians and Gynecologists
    • Preimplantation Genetic Testing [2020]
  • American Journal of Bioethics
    • Implementing Expanded Prenatal Genetic Testing: Should Parents Have Access to Any and All Fetal Genetic Information? [2022]
  • American Journal of Obstetrics & Gynecology
    • Embryo biopsy and maternal and neonatal outcomes following cryopreserved-thawed single embryo transfer [2021]
  • American Society for Reproductive Medicine
    • Clinical management of mosaic results from preimplantation genetic testing for aneuploidy (PGT-A) of blastocysts: a committee opinion [2020]
    • Use of preimplantation genetic testing for monogenic defects (PGT-M) for adult-onset conditions: an Ethics Committee opinion [2018]
    • The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion [2018]
    • Disclosure of sex when incidentally revealed as part of preimplantation genetic testing (PGT): an Ethics Committee opinion [2018]
    • Transferring embryos with genetic anomalies detected in preimplantation testing: an Ethics Committee Opinion [2017]
  • Human Genomics
    • Preimplantation genetic testing for aneuploidy: challenges in clinical practice [2022]
  • JAMA
    • Trends and Outcomes for Preimplantation Genetic Testing in the United States, 2014-2018 [2022]
  • JAMA Network Open
    • Association of State Insurance Mandates for Fertility Treatment With Multiple Embryo Transfer After Preimplantation Genetic Testing for Aneuploidy [2023]
  • Journal of Assisted Reproduction and Genetics
    • Utilization of preimplantation genetic testing in the USA [2021]
    • Preimplantation genetic testing and chances of a healthy live birth amongst recipients of fresh donor oocytes in the United States [2020]
    • Pre-implantation genetic testing alters the sex ratio: an analysis of 91,805 embryo transfer cycles [2020]
  • Society for Assisted Reproductive Technology
    • PGT-A is associated with reduced cumulative live birth rate in first reported IVF stimulation cycles age = 40: an analysis of 133,494 autologous cycles reported to SART CORS [2023]
    • Cumulative live birth rate in women aged =37 years after in vitro fertilization with or without preimplantation genetic testing for aneuploidy: a Society for Assisted Reproductive Technology Clinic Outcome Reporting System retrospective analysis [2022]
    • A SART data cost-effectiveness analysis of planned oocyte cryopreservation versus in vitro fertilization with preimplantation genetic testing for aneuploidy considering ideal family size [2022]
  • Trends in Molecular Medicine
    • Preimplantation Genetic Testing for Aneuploidy – a Castle Built on Sand [2021]
• {Related topics}
  • Topic
    • Prenatal screening and diagnosis
    • Ethics, jurisprudence: reproductive techniques
    • Assisted reproductive techniques

Prenatal screening and diagnosis

• Australia
  • Australian Family Physician
    • Decreased fetal movements: a practical approach in a primary care setting [2014]
  • Better Safer Care
    • Decreased fetal movements
  • NSW Health
    • Prenatal Screening and Diagnostic Testing for Fetal Chromosomal Abnormality
    • Care Pathway for Women Concerned About Fetal Movements
  • Queensland Clinical Guidelines
    • Fetal movements
  • SA Health
    • Low PAPP-A and Normal Chromosomes
    • Decreased Fetal Movements
• Australia, New Zealand
  • Journal of Nuclear Medicine Technology
    • Pregnancy Screening Strategies for Diagnostic Nuclear Medicine: Survey Results from Australia and New Zealand [2013]
  • Perinatal Society of Australia and New Zealand
    • Clinical practice guideline for the care of women with decreased fetal movements for women with a singleton pregnancy from 28 weeks’ gestation [2019]
  • Royal Australian and New Zealand College of Obstetricians and Gynaecologists
    • Screening and diagnosis of fetal structural anomalies and chromosome conditions [2024]
• Austria, Germany, Switzerland
  • Ultraschall in der Medizin
    • Fetal Assessment in Pregnancy (Indication and Methodology for Fetal Monitoring in a low-risk Population). Guideline of the DGGG, DEGUM, OEGGG and SGGG (S3-Level, AWMF Registry No. 015/089, February 2023) [2024]
    • DEGUM, ÖGUM, SGUM and FMF Germany Recommendations for the Implementation of First-Trimester Screening, Detailed Ultrasound, Cell-Free DNA Screening and Diagnostic Procedures [2019]
• Canada
  • British Columbia Medical Journal
    • Prenatal screening options in British Columbia [2018]
  • Canadian Agency for Drugs and Technologies in Health
    • Genetic Carrier Screening for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies, and Spinal Muscular Atrophy [2021]
  • Canadian Association of Radiologists
    • Canadian Association of Radiologists Recommendations for the Safe Use of MRI During Pregnancy [2022]
  • Canadian College of Medical Geneticists
    • Clinical application of fetal genome-wide sequencing during pregnancy: position statement of the Canadian College of Medical Geneticists [2022]
    • Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada [2018]
  • Canadian Family Physician
    • Maternal age–based prenatal screening for chromosomal disorders [2013]
    • Prenatal genetic counseling in cross-cultural medicine: A framework for family physicians [2010]
  • Journal of Obstetrics and Gynaecology Canada
    • Antenatal Fetal Assessment: 75 Years Later (1945-2019) [2019]
  • Ontario Health
    • Carrier Screening Programs for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies and Thalassemia, and Spinal Muscular Atrophy: A Health Technology Assessment [2023]
  • Society of Obstetricians and Gynaecologists of Canada
    • Prenatal Screening for Fetal Chromosomal Anomalies [2024]
    • Antenatal Fetal Health Surveillance [2023]
    • Fetal Health Surveillance: Antepartum Consensus Guideline [2018]
    • Joint SOGC-CCMG Guideline: Update on Prenatal Screening for Fetal Aneuploidy, Fetal Anomalies, and Adverse Pregnancy Outcomes [2017]
    • Amniotic Fluid: Technical Update on Physiology and Measurement [2017]
    • Joint SOGC–CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing [2016]
    • Prenatal Diagnosis Procedures and Techniques to Obtain a Diagnostic Fetal Specimen or Tissue: Maternal and Fetal Risks and Benefits [2015]
• Cuba
  • Journal of Community Genetics
    • SCA2 predictive testing in Cuba: challenging concepts and protocol evolution [2015]
• Denmark
  • Acta Obstetricia et Gynecologica Scandinavica
    • Maternal age and the risk of fetal aneuploidy: A nationwide cohort study of more than 500 000 singleton pregnancies in Denmark from 2008 to 2017 [2024]
• Europe
  • EUROCAT
    • Prenatal Screening Policies in Europe [2010]
  • European Board and College of Obstetrics and Gynaecology
    • Current status and future of genomics in fetal and maternal medicine: A scientific review commissioned by European Board and College of Obstetrics and Gynaecology (EBCOG) [2024]
  • European Molecular Genetics Quality Network
    • EMQN best practice guidelines for genetic testing in dystrophinopathies [2020]
    • EMQN/CMGS best practice guidelines for the molecular genetic testing of Huntington disease [2013]
  • European Society of Human Genetics
    • Recommendations for reporting results of diagnostic genetic testing (biochemical, cytogenetic and molecular genetic) [2014]
  • Journal of Global Health
    • Antenatal screening practices in the WHO European Region: a mixed methods study [2020]
• Germany, Republic of Korea
  • Development & Reproduction
    • Legislation on Genetic Diagnosis: Comparison of South Korea and Germany [2015]
• India
  • Indian Journal of Medical Research
    • Prenatal screening for genetic disorders: Suggested guidelines for the Indian Scenario [2017]
    • Invasive & non-invasive approaches for prenatal diagnosis of haemoglobinopathies: Experiences from India [2011]
• International
  • Intergrowth-21st
    • The INTERGROWTH-21st fetal growth standards: toward the global integration of pregnancy and pediatric care [2018]
  • International Society for Prenatal Diagnosis
    • Joint Position Statement from the International Society for Prenatal Diagnosis (ISPD), the Society for Maternal Fetal Medicine (SMFM), and the Perinatal Quality Foundation (PQF) on the use of genome-wide sequencing for fetal diagnosis [2018]
    • Position Statement from the Chromosome Abnormality Screening Committee on Behalf of the ISPD Board of Directors [2015]
    • Aneuploidy screening: a position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, January 2011 [2011]
  • International Society of Ultrasound in Obstetrics and Gynecology
    • ISUOG Practice Guidelines (updated): performance of fetal magnetic resonance imaging [2023]
    • ISUOG Practice Guidelines: performance of fetal magnetic resonance imaging [2017]
  • PLoS ONE
    • A systematic scoping review to identify the design and assess the performance of devices for antenatal continuous fetal monitoring [2020]
  • Women's Health
    • Exploring measurement tools used to assess knowledge, attitudes, and perceptions of pregnant women toward prenatal screening: A systematic review [2024]
• Ireland
  • Ireland's Health Services
    • Reduced Fetal Movements [2024]
• Italy
  • European Journal of Obstetrics & Gynecology and Reproductive Biology
    • The Italian guidelines on non-invasive and invasive prenatal diagnosis: Executive summary of recommendations for practice the Italian Society for Obstetrics and Gynecology (SIGO) [2024]
  • Società Italiana di Genetica Umana
    • Considerations on the use of carrier screening testing in human reproduction: comparison between recommendations from the Italian Society of Human Genetics and other international societies [2022]
    • Microarray application in prenatal diagnosis: a position statement from the cytogenetics working group of the Italian Society of Human Genetics (SIGU), November 2011 [2012]
• Low and middle income countries
  • PLoS ONE
    • Measurement of symphysis fundal height for gestational age estimation in low-to-middle-income countries: A systematic review and meta-analysis [2022]
  • World Health Organization
    • Community genetics services : report of a WHO consultation on community genetics in low- and middle-income countries [2011]
• Netherlands
  • Paediatric and Perinatal Epidemiology
    • Prenatal diagnosis and pregnancy outcome of major structural anomalies detectable in the first trimester: A population-based cohort study in the Netherlands [2022]
• OECD countries
  • Social Science & Medicine
    • Benefits and harms adopted by health economic assessments evaluating antenatal and newborn screening programmes in OECD countries: A systematic review of 336 articles and reports [2022]
• Poland
  • Ginekologia Polska
    • Recommendations for prenatal diagnostics of the Polish Society of Gynaecologists and Obstetricians and the Polish Society of Human Genetics [2022]
• Republic of Korea
  • Journal of Korean Medical Science
    • Clinical Practice Guidelines for Prenatal Aneuploidy Screening and Diagnostic Testing from Korean Society of Maternal-Fetal Medicine: (1) Prenatal Aneuploidy Screening [2021]
• Sri Lanka
  • Sri Lanka College of Obstetricians & Gynaecologists
    • Managing Reduced Fetal Movements [2023]
• Sweden
  • BMC Pregnancy and Childbirth
    • Prenatal diagnosis in Sweden 2011 to 2013—a register-based study [2016]
• Thailand
  • PLoS ONE
    • Economic evaluation of prenatal screening for fetal aneuploidies in Thailand [2023]
• United Kingdom
  • Applied Health Economics and Health Policy
    • Vision Amniotic Leak Detector (ALD) to Eliminate Amniotic Fluid Leakage as a Cause of Vaginal Wetness in Pregnancy: A NICE Medical Technology Guidance [2015]
  • BMC Pregnancy and Childbirth
    • Evaluation of the quality of guidelines for the management of reduced fetal movements in UK maternity units [2015]
  • Health Technology Assessment
    • MRI in the diagnosis of fetal developmental brain abnormalities: the MERIDIAN diagnostic accuracy study [2019]
  • National Institute for Health and Care Excellence
    • Monitoring fetal growth [2021]
    • Fetal movement monitoring [2021]
    • Vision Amniotic Leak Detector to assess unexplained vaginal wetness in pregnancy [2013]
  • NHS England
    • Rapid exome sequencing service guidance: Fetal anomalies testing [2021]
    • NHS fetal anomaly screening programme (FASP)
    • Fetal anomaly screening: programme handbook
    • Fetal anomaly screening programme: standards
    • Down’s syndrome, Edwards’ syndrome and Patau’s syndrome screening pathway requirements
    • Antenatal and newborn screening: quality assurance procedures
  • Public Health England
    • NHS antenatal and newborn screening programmes: resources for laboratories
    • Fetal anomaly screening: providing services
    • Fetal anomaly screening: care pathways
    • Antenatal and newborn screening: laboratory quality assurance
  • Public Health Scotland
    • Scottish pregnancy screening changes - information needs research 2020 [2020]
  • Public Health Wales
    • Antenatal Screening Wales
  • Royal College of Obstetricians and Gynaecologists
    • Evidence to Support the Clinical Utility of Prenatal Exome Sequencing in the Evaluation of the Fetus with Congenital Anomalies [2021]
    • The Combined Use of Ultrasound and Fetal Magnetic Resonance Imaging for a Comprehensive Fetal Neurological Assessment in Fetal Congenital Cardiac Defects [2019]
    • Diagnostic Biomarkers for Predicting Adverse Early Pregnancy Outcomes [2018]
  • UK National Screening Committee
    • Patau's syndrome
    • Fetal presentation in pregnancy
    • Fetal anomalies
    • Edwards' syndrome
• United States
  • American College of Medical Genetics and Genomics
    • Laboratory testing for preconception/prenatal carrier screening: A technical standard of the American College of Medical Genetics and Genomics (ACMG) [2024]
    • Points to consider in the detection of germline structural variants using next-generation sequencing: A statement of the American College of Medical Genetics and Genomics (ACMG) [2023]
    • Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG) [2021]
    • Direct-to-consumer prenatal testing for multigenic or polygenic disorders: a position statement of the American College of Medical Genetics and Genomics (ACMG) [2021]
    • The use of fetal exome sequencing in prenatal diagnosis: a points to consider document of the American College of Medical Genetics and Genomics (ACMG) [2020]
    • ACMG position statement on prenatal/ preconception expanded carrier screening [2013]
  • American College of Obstetricians and Gynecologists
    • Indications for Outpatient Antenatal Fetal Surveillance [2021]
    • Consumer Testing for Disease Risk [2021]
    • Antepartum Fetal Surveillance: ACOG Practice Bulletin, Number 229 [2021]
    • Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226 [2020]
    • Modern Genetics in Obstetrics and Gynecology [2018]
    • Access to Genetic Testing [2018]
    • Methods for Estimating the Due Date [2017]
    • Management of Suboptimally Dated Pregnancies [2017]
    • Guidelines for Diagnostic Imaging During Pregnancy and Lactation [2017]
    • Counseling About Genetic Testing and Communication of Genetic Test Results [2017]
    • Carrier Screening in the Age of Genomic Medicine [2017]
    • Carrier Screening for Genetic Conditions [2017]
    • Microarrays and Next-Generation Sequencing Technology: The Use of Advanced Genetic Diagnostic Tools in Obstetrics and Gynecology [2016]
  • American College of Radiology
    • ACR-SPR Practice Parameter for the Safe and Optimal Performance of Fetal Magnetic Resonance Imaging (MRI)
  • Association of Women's Health, Obstetric and Neonatal Nurses
    • Decreased Fetal Movement: AWHONN Practice Brief #20 [2024]
  • National Society of Genetic Counselors
    • Genetic counseling for congenital heart disease - Practice resource of the National Society of Genetic Counselors [2022]
    • NSGC practice guideline: prenatal screening and diagnostic testing options for chromosome aneuploidy [2013]
  • Prenatal Diagnosis
    • ACOG and SMFM guidelines for prenatal diagnosis: Is karyotyping really sufficient? [2018]
  • Reproductive Health
    • Latinx individuals' knowledge of, preferences for, and experiences with prenatal genetic testing: a scoping review [2022]
  • Society for Maternal-Fetal Medicine
    • The role of ultrasound in women who undergo cell-free DNA screening [2017]
    • The use of chromosomal microarray for prenatal diagnosis [2016]
    • Fetal blood sampling [2013]
  • StatPearls
    • Prenatal Genetic Screening
• {Related topics}
  • Topic
    • Prenatal ultrasound
    • Preimplantation diagnosis
    • Obstetrics, perinatology
    • Neonatal screening
    • Maternal blood screening, non-invasive prenatal testing
    • Fragile X syndrome: prenatal screening and diagnosis
    • Fetal therapy
    • Ethics, jurisprudence: obstetrics, gynecology, sexual and reproductive rights
    • Down syndrome: prenatal screening and diagnosis
    • Cystic fibrosis: prenatal screening and diagnosis
    • Amniocentesis, chorionic villus sampling

Prenatal ultrasound

• Australia
  • SA Health
    • Ultrasound Soft Markers of Aneuploidy
• Australia, New Zealand
  • Australasian Society for Ultrasound in Medicine
    • Guidelines for the Performance of First Trimester Ultrasound [2021]
    • Normal Ultrasonic Fetal Measurements Standard [2018]
    • Guidelines for the performance of second(mid) trimester US [2018]
    • Guidelines for the Performance of Third Trimester Ultrasound [2014]
• Brazil
  • Revista da Associação Médica Brasileira
    • Ultrasound in the first trimester of pregnancy [2020]
    • What is the role of routine ultrasonography performed in the first trimester of low-risk pregnancy? [2017]
• Canada
  • BMC Pregnancy and Childbirth
    • Factors associated with the timing of the first prenatal ultrasound in Canada [2019]
  • Canadian Agency for Drugs and Technologies in Health
    • Obstetrical Ultrasound During Pregnancy [2021]
  • Canadian Association of Radiologists
    • Canadian Association of Radiologists Obstetrics and Gynecology Diagnostic Imaging Referral Guideline [2024]
  • Public Health Agency of Canada
    • Evaluation of the INTERGROWTH-21st project newborn standard for use in Canada [2017]
  • Society of Obstetricians and Gynaecologists of Canada
    • The Complete 11–14 Week Prenatal Sonographic Examination [2021]
    • Point of Care Ultrasound in Obstetrics and Gynaecology [2021]
    • Determination of Gestational Age by Ultrasound [2019]
    • Clinical Practice Guideline on the Use of First Trimester Ultrasound [2019]
    • Obstetric Ultrasound Biological Effects and Safety [2018]
    • Technical Update: The Role of Early Comprehensive Fetal Anatomy Ultrasound Examination [2017]
    • Content of a Complete Routine Second Trimester Obstetrical Ultrasound Examination and Report [2017]
    • Ultrasound Evaluation of First Trimester Complications of Pregnancy [2016]
• China
  • World Journal of Pediatrics
    • Comparison of updated birth weight, length and head circumference charts by gestational age in China with the INTERGROWTH-21st NCSS charts: a population-based study [2023]
• Denmark
  • Danish Medical Journal
    • Live birth prevalence of atrioventricular septal defect after the implementation of new prenatal screening guidelines [2022]
    • Foetal sex determination at the second trimester anomaly scan in Denmark [2019]
• Ethiopia
  • U.S. Agency for International Development
    • Effect of USAID-funded obstetric ultrasound service interventions on maternal and perinatal health outcomes at primary healthcare facilities in Ethiopia: a propensity score matching analysis [2022]
• Europe
  • European Achondroplasia Forum
    • Optimising the diagnosis and referral of achondroplasia in Europe: European Achondroplasia Forum best practice recommendations [2022]
  • European Association of Perinatal Medicine
    • European association of perinatal medicine (EAPM) position statement: Screening, diagnosis and management of congenital anomalies of the umbilical cord [2024]
• France
  • Acta Obstetricia et Gynecologica Scandinavica
    • Testing the assumptions of customized intrauterine growth charts using national birth studies [2022]
  • BMJ Open
    • Cost and outcomes of the ultrasound screening program for birth defects over time: a population-based study in France [2020]
• Germany
  • Ultraschall in der Medizin
    • The role of ultrasound in first-trimester screening after the introduction of NIPT as a service of public health insurance - a consensus statement of the Fetal Medicine Foundation (FMF) Germany [2023]
• High-income countries
  • Journal of Psychosomatic Obstetrics & Gynecology
    • Impact of first-trimester anomaly scan on health-related quality of life and healthcare costs: a scoping review [2024]
• India
  • Indian Journal of Nephrology
    • Revised guidelines on management of antenatal hydronephrosis [2013]
  • Journal of Fetal Medicine
    • Society of Fetal Medicine Practice Guidelines for the Second Trimester Anomalies Scan [2014]
• India, Sub-Saharan Africa
  • BMJ Open
    • Antenatal Doppler screening for fetuses at risk of adverse outcomes: a multicountry cohort study of the prevalence of abnormal resistance index in low-risk pregnant women [2022]
• International
  • Archives of Gynecology and Obstetrics
    • The diagnostic performance of the ductus venosus for the detection of cardiac defects in the first trimester: a systematic review and diagnostic test accuracy meta-analysis [2023]
  • BMJ Open
    • Portable ultrasound technologies for estimating gestational age in pregnant women: a scoping review and analysis of commercially available models [2022]
  • Intergrowth-21st
    • Fetal growth velocity standards from the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project [2021]
    • Achieving accurate estimates of fetal gestational age and personalised predictions of fetal growth based on data from an international prospective cohort study: a population-based machine learning study [2020]
    • International standards for early fetal size and pregnancy dating based on ultrasound measurement of crown–rump length in the first trimester of pregnancy [2014]
    • Ultrasound methodology used to construct the fetal growth standards in the INTERGROWTH-21st Project [2013]
    • Statistical considerations for the development of prescriptive fetal and newborn growth standards in the INTERGROWTH-21st Project [2013]
    • Standardisation of crown–rump length measurement [2013]
    • Standardisation and quality control of ultrasound measurements taken in the INTERGROWTH-21st Project [2013]
    • Managing data for the international, multicentre INTERGROWTH-21st Project [2013]
    • Fetal biometry: how well can offline measurements from three-dimensional volumes substitute real-time two-dimensional measurements? [2013]
    • Estimation of gestational age in early pregnancy from crown-rump length when gestational age range is truncated: the case study of the INTERGROWTH-21st Project [2013]
    • Conceptual basis for prescriptive growth standards from conception to early childhood: present and future [2013]
  • International Society for Prenatal Diagnosis
    • ISPD 2022 debate-When offering a first trimester ultrasound at 11 + 0 to 13 + 6 weeks, a detailed review of fetal anatomy should be included [2023]
  • International Society of Ultrasound in Obstetrics and Gynecology
    • ISUOG Practice Guidelines: performance of third-trimester obstetric ultrasound scan [2024]
    • ISUOG Practice Guidelines (updated): performance of 11-14-week ultrasound scan [2023]
    • ISUOG Practice Guidelines (updated): fetal cardiac screening [2023]
    • ISUOG Practice Guidelines (updated): performance of the routine mid-trimester fetal ultrasound scan [2022]
    • ISUOG statement on the safe use of Doppler for fetal ultrasound examination in the first 13 + 6 weeks of pregnancy (updated) [2021]
    • ISUOG statement on the non-diagnostic use of ultrasound in pregnancy [2021]
    • ISUOG Practice Guidelines (updated): use of Doppler velocimetry in obstetrics [2021]
    • ISUOG Practice Guidelines (updated): sonographic examination of the fetal central nervous system. Part 2: performance of targeted neurosonography [2021]
    • ISUOG Practice Guidelines (updated): sonographic examination of the fetal central nervous system. Part 1: performance of screening examination and indications for targeted neurosonography [2020]
    • ISUOG Practice Guidelines: ultrasound assessment of fetal biometry and growth [2019]
    • Three-dimensional ultrasound imaging of the fetal skull and face [2017]
    • ISUOG Education Committee recommendations for basic training in obstetric and gynecological ultrasound [2014]
    • ISUOG Practice Guidelines (updated): sonographic screening examination of the fetal heart [2013]
    • Practice guidelines for performance of the routine mid-trimester fetal ultrasound scan [2011]
    • Statements & Guidelines
  • Journal of Maternal-Fetal & Neonatal Medicine
    • Estimated fetal weight standards of the INTERGROWTH-21st project for the prediction of adverse outcomes: a systematic review with meta-analysis [2023]
  • PLoS Medicine
    • The World Health Organization Fetal Growth Charts: A Multinational Longitudinal Study of Ultrasound Biometric Measurements and Estimated Fetal Weight [2017]
  • World Association of Perinatal Medicine
    • Clinical Practice Guidelines and Recommendations by the World Association of Perinatal Medicine and Perinatal Medicine Foundation: Reporting Suspected Findings from Fetal Central Nervous System Examination [2024]
    • First trimester examination of fetal anatomy: clinical practice guideline by the World Association of Perinatal Medicine (WAPM) and the Perinatal Medicine Foundation (PMF) [2022]
    • WAPM-World Association of Perinatal Medicine Practice Guidelines: Fetal central nervous system examination [2021]
• Ireland
  • Ireland's Health Services
    • The Fetal Anatomy Ultrasound [2023]
  • Irish Medical Journal
    • Maternity Ultrasound in the Republic of Ireland 2016; A Review [2017]
• Low and middle income countries
  • BMC Public Health
    • Cost estimation alongside a multi-regional, multi-country randomized trial of antenatal ultrasound in five low-and-middle-income countries [2021]
  • BMJ Paediatrics Open
    • Investigating the use of ultrasonography for the antenatal diagnosis of structural congenital anomalies in low-income and middle-income countries: a systematic review [2020]
• Malta
  • Journal of the Turkish German Gynecological Association
    • The accuracy of antenatal ultrasound screening in Malta: a population-based study [2022]
• Netherlands
  • BMC Pregnancy and Childbirth
    • Informed choice and routinization of the second-trimester anomaly scan: a national cohort study in the Netherlands [2023]
  • Prenatal Diagnosis
    • Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening? [2020]
• New Zealand
  • Health New Zealand
    • New Zealand Obstetric Ultrasound Guidelines [2019]
• Nigeria
  • Pan African Medical Journal
    • Fetal nuchal translucency scan in Nigeria [2014]
• Norway
  • Tidsskrift for Den norske legeforening
    • Flawed recommendation issued by the Norwegian Directorate of Health concerning the determination of fetal age [2015]
• Poland
  • Ginekologia Polska
    • Practice guidelines of the Polish Society of Gynecologists and Obstetricians — Ultrasound Section for ultrasound screening in uncomplicated pregnancy — 2020 [2020]
• Republic of Korea
  • Obstetrics & Gynecology Science
    • 2014 First-trimester ultrasound forum from the Korean Society of Ultrasound in Obstetrics and Gynecology [2015]
• Rwanda
  • BMC Health Services Research
    • Maternal health care professionals’ experiences and views on the use of obstetric ultrasound in Rwanda: A cross-sectional study [2021]
• Sub-Saharan Africa
  • BMC Medical Education
    • The training of midwives to perform obstetric ultrasound scan in Africa for task shifting and extension of scope of practice: a scoping review [2023]
• Sweden
  • Acta Obstetricia et Gynecologica Scandinavica
    • Accuracy and precision of sonographic fetal weight estimation in Sweden [2023]
  • Reproductive Health
    • Adherence to Swedish national pregnancy dating guidelines and management of discrepancies between pregnancy dating methods: a survey study [2019]
• Taiwan
  • Taiwanese Journal of Obstetrics and Gynecology
    • A novel reference chart and growth standard of fetal biometry in the Taiwanese population [2022]
    • A survey of current use, dilemma and outlook of antenatal ultrasonography in Taiwan [2019]
• United Kingdom
  • British Medical Ultrasound Society
    • Professional Guidance for Fetal Growth Scans Performed after 23 weeks of Gestation [2022]
  • Health Technology Assessment
    • Universal late pregnancy ultrasound screening to predict adverse outcomes in nulliparous women: a systematic review and cost-effectiveness analysis [2021]
  • National Institute for Health and Care Excellence
    • Routine third trimester ultrasound for fetal growth [2021]
  • NHS England
    • 20-week screening scan pathway requirements specification
  • Public Health England
    • Early pregnancy scan: brief description
  • Reproductive Sciences
    • Trends in Termination of Pregnancy for Foetal Urological Abnormalities in England and Wales: a Cross-Sectional Study [2023]
  • Royal College of Obstetricians and Gynaecologists
    • Ultrasound from Conception to 10+0 Weeks of Gestation [2015]
• United States
  • American College of Radiology
    • Second and Third Trimester Screening for Fetal Anomaly
    • Nuchal Translucency Evaluation at 11 to 14 Weeks Gestational Age
    • Antenatal Hydronephrosis-Infant
    • ACR–ACOG–AIUM–SMFM–SRU Practice Parameter for the Performance of Standard Diagnostic Obstetrical Ultrasound
  • American Institute of Ultrasound in Medicine
    • AIUM Practice Parameter for the Performance of Standard Diagnostic Obstetric Ultrasound [2024]
    • AIUM Official Statement: Conclusions Regarding Epidemiology for Obstetric Ultrasound [2023]
    • AIUM Practice Parameter for the Performance of Detailed Diagnostic Obstetric Ultrasound Examinations Between 12 Weeks 0 Days and 13 Weeks 6 Days [2021]
    • AIUM Practice Parameter for the Performance of Fetal Echocardiography [2020]
    • AIUM Practice Parameter for the Performance of Detailed Second- and Third-Trimester Diagnostic Obstetric Ultrasound Examinations [2019]
    • AIUM-ACR-ACOG-SMFM-SRU Practice Parameter for the Performance of Standard Diagnostic Obstetric Ultrasound Examinations [2018]
    • AIUM Practice Parameter for the Performance of Limited Obstetric Ultrasound Examinations by Advanced Clinical Providers [2018]
    • Obstetric Ultrasound
    • Fetal Echocardiography
  • American Society of Echocardiography
    • Guidelines and Recommendations for Performance of the Fetal Echocardiogram: An Update from the American Society of Echocardiography [2023]
  • National Institute of Child Health and Human Development
    • Unified standard for fetal growth: the Eunice Kennedy Shriver National Institute of Child Health and Human Development Fetal Growth Studies [2022]
    • Estimating Gestational Age From Ultrasound Fetal Biometrics [2017]
  • Society for Maternal-Fetal Medicine
    • Executive summary: Workshop on developing an optimal maternal-fetal medicine ultrasound practice, February 7-8, 2023, cosponsored by the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, American Institute of Ultrasound in Medicine, American Registry for Diagnostic Medical Sonography, International Society of Ultrasound in Obstetrics and Gynecology, Gottesfeld-Hohler Memorial Foundation, and Perinatal Quality Foundation [2023]
    • Society for Maternal-Fetal Medicine Special Statement: Best-practice recommendations for ultrasound network connectivity [2022]
    • Society for Maternal-Fetal Medicine Consult Series #57: Evaluation and management of isolated soft ultrasound markers for aneuploidy in the second trimester [2021]
    • SMFM Fetal Anomalies Consult Series #4: Genitourinary anomalies [2021]
    • Vein of Galen Aneurysmal Malformation [2020]
    • SMFM Special Statement: Reducing the risk of transmitting infection by transvaginal ultrasound examination [2020]
    • SMFM Fetal Anomalies Consult Series #3: Intracranial Anomalies [2020]
    • Posterior Encephalocele [2020]
    • Intracranial Hemorrhage [2020]
    • Intracranial Cysts [2020]
    • Holoprosencephaly [2020]
    • Fetal Ventriculomegaly [2020]
    • Exencephaly-anencephaly Sequence [2020]
    • Dandy-Walker Malformation [2020]
    • Agenesis of the Corpus Callosum [2020]
    • Absent Cavum Septi Pellucidi [2020]
    • SMFM Fetal Anomalies Consult Series #2: Extremities [2019]
    • SMFM Fetal Anomalies Consult Series #1: Facial Anomalies [2019]
    • Radial Ray Malformation [2019]
    • Polydactyly [2019]
    • Paramedian Orofacial Cleft [2019]
    • Micrognathia [2019]
    • Median Facial Cleft [2019]
    • Hypotelorism [2019]
    • Hypertelorism [2019]
    • Congenital talipes equinovarus (clubfoot) [2019]
    • Arthrogryposis [2019]
    • Anophthalmia and Microphthalmia [2019]
    • Amniotic Band Sequence [2019]
    • Absent nasal bone [2019]
  • Society of Radiologists in Ultrasound
    • A Lexicon for First-Trimester US: Society of Radiologists in Ultrasound Consensus Conference Recommendations [2024]
  • Ultrasound in Obstetrics & Gynecology
    • Detection of fetal cardiac anomalies: cost-effectiveness of increased number of cardiac views [2020]
• WHO
  • World Health Organization
    • Maternal and fetal assessment update: imaging ultrasound before 24 weeks of pregnancy [2022]
    • Imaging ultrasound before 24 weeks of pregnancy: 2022 update to the WHO antenatal care recommendations for a positive pregnancy experience [2022]
    • WHO recommendations on antenatal care for a positive pregnancy experience: ultrasound examination [2018]
    • Fetal Growth Calculator
• {Related topics}
  • Topic
    • Prenatal screening and diagnosis